Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
AKANTIOR® (polihexanide) stands to become first approved drug for the treatment of acanthamoeba keratitis in the world. It is an anti-amoebic polymer that acts on both the trophozoites and cysts of the protozoan Acanthamoeba.
Lead Product(s): Polyhexanide
Therapeutic Area: Infections and Infectious Diseases Product Name: Akantior
Highest Development Status: Phase IIIProduct Type: Small molecule
Recipient: SIFI
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable June 07, 2022